• Citer

HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma.

par Nielsen, Trine O;Poulsen, Steen S;Journé, Fabrice ;Ghanem, Ghanem Elias ;Sorensen, Boe S
Référence Melanoma research, 24, 1, page (88-91)
Publication Publié, 2014-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma.
Auteur:	Nielsen, Trine O; Poulsen, Steen S; Journé, Fabrice; Ghanem, Ghanem Elias; Sorensen, Boe S
Informations sur la publication:	Melanoma research, 24, 1, page (88-91)
Statut de publication:	Publié, 2014-02
Sujet CREF:	Cancérologie
Mots-clés:	alternative splicing
	CYT1
	CYT2
	epidermal growth factor
	epidermal growth factor receptor
	ErbB3
	ErbB4
	HER3
	HER4
	malignant melanoma
MeSH keywords:	Aged
	Aged, 80 and over
	Disease-Free Survival
	Female
	Humans
	Immunohistochemistry
	Isoenzymes -- metabolism
	Male
	Melanoma -- enzymology -- genetics
	Middle Aged
	Prognosis
	Receptor, Epidermal Growth Factor -- genetics -- metabolism
	Receptor, ErbB-4
	Skin Neoplasms -- enzymology -- genetics
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0960-8931
	info:doi/10.1097/CMR.0000000000000040
	info:pii/00008390-201402000-00012
	info:scp/84891871646
	info:pmid/24366194